CARY, N.C., March 9, 2011 /PRNewswire/ -- iAdvantage Software, Inc., a leading solutions provider for managing development and pre-clinical life science studies, today announced that BioTox Sciences (BTS), a GLP…
Company to Focus on Generation of Revenues From Commercialization of Drug Pipeline Based on NexACT(R) Delivery Technology SAN DIEGO, July 6, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio")…
SAN DIEGO, January 31, 2012 – BioTox Sciences is pleased to share that their most recent FDA audit was met with no deviations from the regulations. No observations, 483's or…
San Francisco, March 11-15, 2012 – BioTox Sciences attends the SOT's Annual Meeting and Toxicology Expo at the Moscone Convention Center in San Francisco, California. The Annual Meeting is the…
CHICAGO, March 31, 2012 – BioTox Sciences attends the American Association for Cancer Research Annual Meeting in Chicago, Illinois. The American Association for Cancer Research Annual Meeting serves as the…
SAN DIEGO, APRIL 17-19, 2012 – BioTox Sciences attends the Cambridge Healthtech Institue's Seventh Annual Drug Discovery Chemistry at Hilton San Diego Resort & Spa.
SAN DIEGO, MAY 14, 2012 – Following the acquisition of Bio-Quant, Inc., BioTox Sciences is pleased to announce the successful merger of all accreditations.
SAN DIEGO, JUNE 18, 2012 – BioTox Sciences operates two vivaria (21,000 sq ft and 12,500 sq ft) that provide the following benefits: Small and large housing rooms, AAALAC compliant…
SAN DIEGO, OCTOBER 16, 2012 – BioTox Sciences launches its new website. A refined and valuable resource for your Discovery to IND Preclinical needs.
SAN ANTONIO, MARCH 10-14, 2013 – BioTox Sciences to participate in the 2013 SOT to be held in San Antonio, Texas at The Henry Gonzales Convention Center.